BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23935264)

  • 1. The new biology: a bridge to clinical cardiology.
    Louridas G; Lourida K
    Hippokratia; 2012 Apr; 16(2):106-12. PubMed ID: 23935264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic translational research: Paving the way to individualized cardiac functional analyses and personalized cardiology.
    Pasipoularides A
    Int J Cardiol; 2017 Mar; 230():384-401. PubMed ID: 28057368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational bioinformatics and systems biology approaches for personalized medicine.
    Yan Q
    Methods Mol Biol; 2010; 662():167-78. PubMed ID: 20824471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized Management of Cardiovascular Disorders.
    Jain KK
    Med Princ Pract; 2017; 26(5):399-414. PubMed ID: 28898880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
    Alaaeddine R; Fayad M; Nehme E; Bahmad HF; Kobeissy F
    Adv Exp Med Biol; 2017; 1007():59-70. PubMed ID: 28840552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach.
    Zhang A; Sun H; Wang P; Han Y; Wang X
    Complement Ther Med; 2012; 20(1-2):93-9. PubMed ID: 22305254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting synergistic research and education in genomics and bioinformatics.
    Yang JY; Yang MQ; Zhu MM; Arabnia HR; Deng Y
    BMC Genomics; 2008; 9 Suppl 1(Suppl 1):I1. PubMed ID: 18366597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine.
    Weston AD; Hood L
    J Proteome Res; 2004; 3(2):179-96. PubMed ID: 15113093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management.
    Soni A; Gowthamarajan K; Radhakrishnan A
    Int J Pharm Compd; 2018; 22(2):108-121. PubMed ID: 29877858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of drug discovery for personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis.
    Ghasemi M; Nabipour I; Omrani A; Alipour Z; Assadi M
    Am J Nucl Med Mol Imaging; 2016; 6(6):310-327. PubMed ID: 28078184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future challenges of biomedical informatics for translational medicine.
    López-Alonso V; Hermosilla-Gimeno I; López-Campos G; Mayer MA;
    Stud Health Technol Inform; 2013; 192():942. PubMed ID: 23920716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-Generation Sequencing: The Translational Medicine Approach from "Bench to Bedside to Population".
    Beigh MM
    Medicines (Basel); 2016 Jun; 3(2):. PubMed ID: 28930123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm.
    Massoud TF; Gambhir SS
    Trends Mol Med; 2007 May; 13(5):183-91. PubMed ID: 17403616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoinformatics and DNA-based computing: catalyzing nanomedicine.
    Maojo V; Martin-Sanchez F; Kulikowski C; Rodriguez-Paton A; Fritts M
    Pediatr Res; 2010 May; 67(5):481-9. PubMed ID: 20118825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges for the implementation of high-throughput testing and liquid biopsies in personalized medicine cancer trials.
    Verlingue L; Alt M; Kamal M; Sablin MP; Zoubir M; Bousetta N; Pierga JY; Servant N; Paoletti X; Le Tourneau C
    Per Med; 2014 Jul; 11(5):545-558. PubMed ID: 29758779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker-driven feedback control of synthetic biology systems for next-generation personalized medicine.
    Stefanov BA; Fussenegger M
    Front Bioeng Biotechnol; 2022; 10():986210. PubMed ID: 36225597
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.